EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Narrative Review of Human Clinical Trials to Improve Lactose Digestion and Tolerance by Feeding Bifidobacteria or Galacto-Oligosacharides

Sindusha Mysore Saiprasad, Olivia Grace Moreno, Dennis A Savaiano iD

Nutrients · 2023

DOI: 10.3390/nu15163559 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Sindusha Mysore Saiprasad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Lactose, Lactose Intolerance. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Supplementation with the probiotic Bifidobacterium and prebiotic galacto-oligosaccharides (GOS) could improve gut health and benefit lactose intolerant individuals. A narrative review was conducted to identify human clinical trials that evaluated lactose digestion and/or tolerance in response to consumption of Bifidobacterium, GOS, or both. A total of 152 studies on Bifidobacterium and GOS or both were published between 1983 and 2022. Out of the 152 studies, 20 were human clinical trials conducted in lactose intolerant subjects; 8 studies were conducted with Bifidobacterium supplementation and 3 studies involved GOS supplementation. Five studies reported favorable outcomes of Bifidobacterium supplementation in managing lactose intolerance (LI). Similarly, three studies reported favorable outcomes with GOS supplementation. The other three studies reported neutral outcomes. In conclusion, most studies reported a favorable effect of Bifidobacterium and GOS on managing the symptoms of LI. No study has examined the effects of combined supplementation with Bifidobacterium and GOS in lactose intolerant subjects. Future research could examine if co-supplementation with Bifidobacterium and GOS is a more effective strategy to reduce the dairy discomfort in LI individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoseLactose IntoleranceHumansBifidobacteriumDigestionImmune ToleranceClinical Trials as Topic

Stichwörter der Autor:innen

Bifidobacteriumgalacto-oligosaccharideslactose intoleranceprebioticsprobiotics

Substanzen

Lactose

Autor:innen und Institutionen

  • Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA.

ORCID-Profile: Dennis A Savaiano

Zitieren

APA

Mysore Saiprasad, S., Moreno, O. G., & Savaiano, D. A. (2023). A Narrative Review of Human Clinical Trials to Improve Lactose Digestion and Tolerance by Feeding Bifidobacteria or Galacto-Oligosacharides. Nutrients. https://doi.org/10.3390/nu15163559

Vancouver

Mysore Saiprasad S, Moreno OG, Savaiano DA. A Narrative Review of Human Clinical Trials to Improve Lactose Digestion and Tolerance by Feeding Bifidobacteria or Galacto-Oligosacharides. Nutrients. 2023. doi:10.3390/nu15163559

BibTeX
@article{MysoreSaiprasad2023,
  author = {Mysore Saiprasad, Sindusha and Moreno, Olivia Grace and Savaiano, Dennis A},
  title = {A Narrative Review of Human Clinical Trials to Improve Lactose Digestion and Tolerance by Feeding Bifidobacteria or Galacto-Oligosacharides},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15163559}
}
Kostenlos starten →